Pathway maps

Development_CNTF receptor signaling
Development_CNTF receptor signaling

Object List (links open in MetaCore):

CNTF receptor, c-Raf-1, PI3K reg class IA, p70 S6 kinase2, Tuberin, MEK2(MAP2K2), SOS, RHEB2, SOCS3, CLF-1, glycosylphosphatidylinositol, CNTFR alpha, gp130, ATP + phosphatidylinositol 4,5-bisphosphate = ADP + phosphatidylinositol 3,4,5-trisphosphate, Shc, JAK2, H-Ras, ERK1/2, JAK1, PtdIns(4,5)P2, SHP-2, PI3K cat class IA, c-Fos, STAT3, BSF-3 (cardiotrophin-like cytokine), p70 S6 kinase1, CNTF, PtdIns(3,4,5)P3, GRB2, STAT1, LIFR, AKT(PKB), mTOR, MEK1(MAP2K1)

Description

CNTF receptor signaling

Ciliary neurotrophic factor receptor ( CNTF receptor) is a tripartite complex formed by a specific alpha subunit Ciliary neurotrophic factor receptor ( CNTFR alpha ) and two beta subunits, Leukemia inhibitory factor receptor ( LIFR ) and Interleukin 6 signal transducer ( gp130 ). CNTF receptor is implicated in multiple signal transduction pathways [1], [2], [3]. CNTFR alpha is active in either membrane-bound, or soluble form. [4]. Membrane-bound CNTFR alpha is anchored to the plasma membrane by a glycosylphosphatidylinositol linkage [5], [6].

Signal transduction pathways activated by stimulation of CNTF receptor affect survival, regeneration, proliferation, differentiation, activation or cell death in different cell types [3], [6], [7].

Two ligands of CNTF receptor are Ciliary neurotrophic factor ( CNTF ) and Cardiotrophin-like cytokine ( BSF-3 (cardiotrophin-like cytokine) ) that associates with the soluble orphan receptor cytokine-like factor-1 ( CLF-1 ) to form a functional heteromeric ligand for the CNTF receptor complex. heterodimeric composite cytokine [8], [9], [10]

The main difference between BSF-3 (cardiotrophin-like cytokine)/ CLF-1 and CNTF is that the former only binds to the membrane bound form of CNTFR alpha, while CNTF binds both soluble, and membrane bound forms [6].

Intracellular signaling through CNTF receptor involves three major signal transduction pathways: Janus kinases (JAKs)/ Signal transducer and activators (STATs) [9], [11], [12], Mitogen-activated protein kinases 1-3 ( ERK1/2 ) [9], [11], [12], and Phosphatidylinositol 3-kinase ( PI3K )/ V-akt murine thymoma viral oncogene homolog 1 ( AKT(PKB) ) signaling cascades [13], [9], [14].

Formation of CNTF receptor complex leads to activation of JAKs / STATs pathways [15], [8], [12]. STATs then translocate to the nucleus where they activate transcription of target genes such as cellular oncogene v-fos FBJ murine osteosarcoma viral oncogene homolog ( c-Fos ) [11], [16], Suppressor of cytokine signaling 3 ( SOCS-3 ) [16] or certain gap junctional proteins [12].

SOCS-3 can inhibit CNTF signaling [17], probably via inhibition of JAKs and/or gp130 subunit [18].

In addition, JAK2 phosphorylates CNTF receptor -activated Protein tyrosine phosphatase, non-receptor type 11 ( SHP-2 ) [19], [20], [9]. SHP-2 inhibits JAKs / STATs pathway via dephosphorylation of JAK2 and/or LIFR/ gp130 heterodimer [20], [18]. On the other hand, CNTF receptor -activated SHP-2 induces activation of ERK1/2 and PI3K signaling cascades [9]

JAK2 and JAK2 -activated SHP-2 activates PI3K/ AKT(PKB). AKT(PKB) and stimulates cell survival [6], [7], as well as accelerates necrotic cell death during hypoxia [21], [7]. In addition, PI3K/ AKT(PKB) activates FK506 binding protein 12-rapamycin associated protein 1 ( mTOR )/ ribosomal protein S6 kinase, 70kDa, polypeptides 1 and 2 ( p70 S6 kinase 1, p70 S6 kinases 2 ) signaling cascades, thus stimulating translation [9], [14]. CNTF -activated mTOR may phosphorylate Signal transducer and activator of transcription 3 ( STAT3 ) and thus regulates transcription of STAT3 target genes [13].

Moreover, JAK2 and JAK2 -activated SHP-2 activates Src homology 2 domain containing transforming protein 1 ( Shc )/ Growth factor receptor-bound protein 2 ( Grb2 )/ v-Ha-ras Harvey rat sarcoma viral oncogene homolog ( H-Ras )/ v-raf-1 murine leukemia viral oncogene homolog 1 ( c-Raf-1 )/ Mitogen-activated protein kinase kinases 1 and 2 ( MEK1(MAP2K1) and MEK2(MAP2K2) )/ ERK1/2 cascade [9], [11], [14]. It is possible, that activation of the c-Fos is one of the functions of the CNTF receptor -activated ERK1/2 [11], [22], [16].

References:

  1. Davis S, Aldrich TH, Ip NY, Stahl N, Scherer S, Farruggella T, DiStefano PS, Curtis R, Panayotatos N, Gascan H
    Released form of CNTF receptor alpha component as a soluble mediator of CNTF responses. Science 1993 Mar 19;259(5102):1736-9
  2. Dalhoff A, Petersen U, Endermann R
    In vitro activity of BAY 12-8039, a new 8-methoxyquinolone. Chemotherapy 1996 Nov-Dec;42(6):410-25
  3. Turnley AM, Bartlett PF
    Cytokines that signal through the leukemia inhibitory factor receptor-beta complex in the nervous system. Journal of neurochemistry 2000 Mar;74(3):889-99
  4. Di Marco A, Gloaguen I, Demartis A, Saggio I, Graziani R, Paonessa G, Laufer R
    Agonistic and antagonistic variants of ciliary neurotrophic factor (CNTF) reveal functional differences between membrane-bound and soluble CNTF alpha-receptor. The Journal of biological chemistry 1997 Sep 12;272(37):23069-75
  5. Davis S, Aldrich TH, Valenzuela DM, Wong VV, Furth ME, Squinto SP, Yancopoulos GD
    The receptor for ciliary neurotrophic factor. Science 1991 Jul 5;253(5015):59-63
  6. Vergara C, Ramirez B
    CNTF, a pleiotropic cytokine: emphasis on its myotrophic role. Brain research. Brain research reviews. 2004 Dec;47(1-3):161-73
  7. Park K, Luo JM, Hisheh S, Harvey AR, Cui Q
    Cellular mechanisms associated with spontaneous and ciliary neurotrophic factor-cAMP-induced survival and axonal regeneration of adult retinal ganglion cells. The Journal of neuroscience : the official journal of the Society for Neuroscience 2004 Dec 1;24(48):10806-15
  8. Elson GC, Lelievre E, Guillet C, Chevalier S, Plun-Favreau H, Froger J, Suard I, de Coignac AB, Delneste Y, Bonnefoy JY, Gauchat JF, Gascan H
    CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex. Nature neuroscience 2000 Sep;3(9):867-72
  9. Lelievre E, Plun-Favreau H, Chevalier S, Froger J, Guillet C, Elson GC, Gauchat JF, Gascan H
    Signaling pathways recruited by the cardiotrophin-like cytokine/cytokine-like factor-1 composite cytokine: specific requirement of the membrane-bound form of ciliary neurotrophic factor receptor alpha component. The Journal of biological chemistry 2001 Jun 22;276(25):22476-84
  10. Perret D, Guillet C, Elson G, Froger J, Plun-Favreau H, Rousseau F, Chabbert M, Gauchat JF, Gascan H
    Two different contact sites are recruited by cardiotrophin-like cytokine (CLC) to generate the CLC/CLF and CLC/sCNTFRalpha composite cytokines. The Journal of biological chemistry 2004 Oct 15;279(42):43961-70
  11. Kuroda H, Sugimoto T, Horii Y, Sawada T
    Signaling pathway of ciliary neurotrophic factor in neuroblastoma cell lines. Medical and pediatric oncology 2001 Jan;36(1):118-21
  12. Ozog MA, Bernier SM, Bates DC, Chatterjee B, Lo CW, Naus CC
    The complex of ciliary neurotrophic factor-ciliary neurotrophic factor receptor alpha up-regulates connexin43 and intercellular coupling in astrocytes via the Janus tyrosine kinase/signal transducer and activator of transcription pathway. Molecular biology of the cell 2004 Nov;15(11):4761-74
  13. Yokogami K, Wakisaka S, Avruch J, Reeves SA
    Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Current biology : CB 2000 Jan 13;10(1):47-50
  14. Ott V, Fasshauer M, Dalski A, Klein HH, Klein J
    Direct effects of ciliary neurotrophic factor on brown adipocytes: evidence for a role in peripheral regulation of energy homeostasis. The Journal of endocrinology 2002 May;173(2):R1-8
  15. Bonni A, Frank DA, Schindler C, Greenberg ME
    Characterization of a pathway for ciliary neurotrophic factor signaling to the nucleus. Science 1993 Dec 3;262(5139):1575-9
  16. Kelly JF, Elias CF, Lee CE, Ahima RS, Seeley RJ, Bjorbaek C, Oka T, Saper CB, Flier JS, Elmquist JK
    Ciliary neurotrophic factor and leptin induce distinct patterns of immediate early gene expression in the brain. Diabetes 2004 Apr;53(4):911-20
  17. Bjorbaek C, Elmquist JK, El-Haschimi K, Kelly J, Ahima RS, Hileman S, Flier JS
    Activation of SOCS-3 messenger ribonucleic acid in the hypothalamus by ciliary neurotrophic factor. Endocrinology 1999 May;140(5):2035-43
  18. Clahsen T, Lehmann U, Stross C, Hermanns HM, Volkmer-Engert R, Schneider-Mergener J, Heinrich PC, Schaper F
    The tyrosine 974 within the LIF-R-chain of the gp130/LIF-R heteromeric receptor complex mediates negative regulation of LIF signalling. Cellular signalling 2005 May;17(5):559-69
  19. Stahl N, Farruggella TJ, Boulton TG, Zhong Z, Darnell JE Jr, Yancopoulos GD
    Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 1995 Mar 3;267(5202):1349-53
  20. Servidei T, Aoki Y, Lewis SE, Symes A, Fink JS, Reeves SA
    Coordinate regulation of STAT signaling and c-fos expression by the tyrosine phosphatase SHP-2. The Journal of biological chemistry 1998 Mar 13;273(11):6233-41
  21. Aki T, Mizukami Y, Oka Y, Yamaguchi K, Uemura K, Fujimiya T, Yoshida K
    Phosphoinositide 3-kinase accelerates necrotic cell death during hypoxia. The Biochemical journal 2001 Sep 1;358(Pt 2):481-7
  22. Murphy LO, Smith S, Chen RH, Fingar DC, Blenis J
    Molecular interpretation of ERK signal duration by immediate early gene products. Nature cell biology 2002 Aug;4(8):556-64